Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab
Stopped No patients were enrolled and global prioritization of pipeline and research strategy
Conditions
Interventions
Sponsor
Novartis Pharmaceuticals